Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain

Synapse

Volumn 25, Issue 4, 1997, Pages 321-325

  Ginovart, Nathalie ^a   Farde, Lars ^a   Halldin, Christer ^a   Swahn, Carl Gunnar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B(max); D2 receptors; dopamine; K(D)(app); positron emission tomography; reserpine

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE; RESERPINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING COMPETITION; CONTROLLED STUDY; CORPUS STRIATUM; MALE; MONKEY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ANIMALS; BINDING, COMPETITIVE; BRAIN; CARBON RADIOISOTOPES; DOPAMINE; DOPAMINE ANTAGONISTS; KINETICS; MACACA FASCICULARIS; MALE; MODELS, THEORETICAL; RACLOPRIDE; RADIOLIGAND ASSAY; RECEPTORS, DOPAMINE D2; RESERPINE; SALICYLAMIDES; SYNAPSES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030949522     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199704)25:4<321::AID-SYN2>3.0.CO;2-C     Document Type: Article

References (27)

1. Church, W.H., Justice, J.B., and Neill, D.B. (1987) Detecting behaviorally relevant changes in extracellular dopamine with microdialysis. Brain Res., 412:397-399.
2. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse, 13:350-356.
3. Farde, L., Hall, H., Ehrin, E., and Sedvall, G. (1986) Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science, 231:258-261.
4. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatr., 45:71-76.
5. 2-dopamine receptors studied by PET - A comparison to the equilibrium analysis. J. Cereb. Blood Flow Metabol., 9:696-708.
6. 2-dopamine receptor characteristics in neuroleptic-naive patients with schizophrenia. Arch. Gen. Psychiatr., 47:213-219.
7. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch. Gen. Psychiatr., 49:538-544.
8. 11C]raclopride in man. Synapse, 20:200-208.
9. Fisher, R.E., Morris, E.D., Alpert, N., and Fischman, A.J. (1995) In vivo imaging of neuromodulatory synaptic transmission using PET: A review of relevant neurophysiology. Human Brain Mapping, 3:24-34.
10. Gonon, F.G., and Buda, M.J. (1985) Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience, 14:765-774.
11. 2 receptor binding. Nucl Med. Biol., 18:871-881.
12. Halldin, C., Swahn, C.G., Farde, L., and Sedvall, G. (1995) Radioligand disposition and metabolism - Key information in early drug development. In: PET for Drug Development and Evaluation. D. Comar, ed. Kluwer Academic Publishers, Dordrecht, pp. 55-65.
13. Hume, S.P., Myers, R., Bloomfield, P.M., Opacka-Juffry, J., Cremer, J.E., Ahier, R.G., Luthra, S.K., Brooks, D.J., and Lammerstsma, A.A. (1992) Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse, 12:47-54.
14. 11C]raclopride binding in rat striatum, quantified using PET. Synapse, 21:45-53.
15. 18F:fluoroethylspiperone using positron emission tomography. J. Cereb. Blood Flow Metabol., 10:720-726.
16. 11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology, 113:149-156.
17. Kuczenski, R. (1977) Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools. J. Pharmacol. Exp. Ther., 201:357-367.
18. Lannes, B., Micheletti, G., Warter, J.M., Kempf, E., and Di Scala, G. (1991) Behavioral, pharmacological and biochemical effects of acute and chronic administration of ketamine in the rat. Neurosci. Lett., 128:177-181.
19. 3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA, 89:8155-8159.
20. Naudon, L., Leroux-Nicollet, I., Raisman-Vozari, R., Botton, D., and Costentin, J. (1995) Time-course of modifications elicited by reserpine on the density and mRNA synthesis of the vesicular monoamine transporter, and on the density of the membrane dopamine uptake complex. Synapse, 21:29-36.
21. 11C]methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey. Brain Res., 663:191-198.
22. 3H-raclopride in the mouse brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol., 340:6-12.
23. 3H] raclopride: Implications for positron emission tomography of the human brain. Synapse, 3:96-97.
24. 3) as a target for neuroleptics. Nature, 347:146-151.
25. 11C]raclopride in the human brain. Synapse, 16:255-262.
26. Wienhard, K., Dahldom, M., Eriksson, L., Michel, C., Bruckbauer, T., Pietrzyk, U., and Heiss, W.D. (1994) The ECAT EXACT HR: Performance of a new high resolution positron scanner. J. Comp. Assist. Tomogr., 18:110-118.
27. 3H]raclopride binding in the rat brain. Synapse, 9:188-194.